CLINICAL_TRIALS
trial_result
· 2016-02-08
Clinical Trial Update: Risperdal Consta for Bipolar Disorder [Phase 3]
Summary
A Phase 3 trial evaluating Risperdal Consta for Bipolar I Disorder has completed, and the trial results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pittsburgh | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2016-02-08